BioCentury
ARTICLE | Clinical News

IV carnexiv carbamazepine regulatory update

October 17, 2016 7:00 AM UTC

FDA approved an NDA from H. Lundbeck for IV Carnexiv carbamazepine as short-term replacement therapy for oral carbamazepine to treat seizures in adults who temporarily cannot take their oral formulati...